About Blacktrace
Blacktrace is a scientific company which designs, develops and manufactures cutting-edge technologies and products for many applications used in chemistry, microfluidics, biology, nanomaterial sciences and more.
Maven’s investment supported the company’s world-class innovation in microfluidics as well as the continuous development and launch of advanced scientific products for a wide range on international markets.
In July 2023, Maven exited Blacktrace via a sale to Unchained Labs, a U.S. corporate backed by the Carlyle Group delivering a 2.74x return for Maven Investor Partners.
Why we invested
-
Established, high tech and profitable high growth business
-
Significant spend in R&D with range of products ready to go to market
-
Highly skilled workforce, led by experienced and ambitious management team
-
Established global sales and distribution network
-
High forecasted CAGR for the sector